Both M-CSF and GM-CSF/IFNγ differentiated CAR macrophages and led to a glioma cell reduction of up to 30%, whereas control CARΔ(CD3ζ)-expressing macrophages reduced glioma cell numbers to a lesser extent (Figure 6B). The gene discussed is CD247; the disease is central nervous system cancer.